Waldencast Acquisition Corp. Class A WALD 深 滬
已收盤 07-25 16:00:00 美东时间
2.28
-0.130
-5.39%
華盛通- 最 高2.39
- 今 開2.39
- 成交量 6.89万股
- 最 低 2.26
- 昨 收 2.41
- 總市值 2.80亿
- 52周最高 4.7399
- 市盈率 靜 --
- 換手率 0.06%
- 52周最低 1.98
- 委 比 41.33%
- 總股本 1.23亿
- 歷史最高 12.10
- 量 比 0.76
- 振 幅 5.39%
- 歷史最低 1.98
- 每 手 1
- 風險率 0.51%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Waldencast Strengthens Obagi Medical With Saypha Injectable Line And Novaestiq Acquisition, Expanding Into $2B US Dermal Filler Market
Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolioNew products position Obagi Medical at the forefront of health, beauty and aesthetics convergence
07-23 18:51
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
Waldencast plc has acquired Novaestiq Corp. and the U.S. rights to Saypha® hyaluronic acid (HA) injectable gels, expanding Obagi Medical's product offerings into the growing U.S. dermal filler market. The acquisition aims to position Obagi Medical as a leader in integrated skincare and aesthetic solutions. Saypha®, which is undergoing FDA approval, is a globally recognized, effective, and safe HA injectable with a strong clinical backing and pati...
07-23 10:45
Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining aroun...
06-26 20:16
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
Canaccord Genuity Maintains Buy on Waldencast, Lowers Price Target to $5
Canaccord Genuity analyst Susan Anderson maintains Waldencast (NASDAQ:WALD) with a Buy and lowers the price target from $6 to $5.
05-15 20:18
Waldencast Reports Q1 2025 Financial Performance
Waldencast Acquisition Corp. ( ($WALD) ) has released its Q1 earnings. Here is ...
05-15 12:28
Waldencast shares are trading lower after the company reported a year-over-year decrease in Q1 sales results.
Waldencast shares are trading lower after the company reported a year-over-year...
05-14 22:12
Waldencast Q1 Sales $65.40M Down From $68.30M YoY
Waldencast (NASDAQ:WALD) reported $65.40 million in sales this quarter. This is a 4.25 percent decrease over sales of $68.30 million the same period last year.
05-14 04:41
Waldencast Q1 Preview: Beauty Brand Glow Dims On Soft Margins, Flat Sales
WALD is reporting Q1 results on May 13, Telsey Advisory Group expects margin and earnings miss. Analyst Dana Telsey maintains outperform rating.
05-07 01:09
